You are leaving our website

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.

Alliance:

  • Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
  • Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
  • Privacy and security policies do not apply to third-party websites.
or Decline

A model for success

Our business model sets out how we execute our strategy to deliver on our purpose: making a difference to people’s lives, through making a range of clinically valuable healthcare products available to consumers and patients around the world

Our primary expertise lies in the marketing and management of our products, working collaboratively with colleagues, customers and partners.

Maintaining an asset-light business model and outsourcing capital intensive activities such as manufacturing, storage and logistics to leading specialist organisations in these fields, we can maintain our focus on what we do best.

  • Invest
  • Maintain
  • Acquire

Selectively investing in our brands

Using our deep sector expertise, marketing skills, and technical capabilities to invest in selected brands, primarily Consumer Healthcare brands, to accelerate their growth.

Maintaining our heritage pharma brands

These remain a good source of cash generation for us and so continue to benefit from our established expertise in the management of many types of regulated medical products.

Selectively acquiring new brands

To supplement our existing portfolio and provide new opportunities for growth.